144 ·Filed Jun 30, 2026
Form 144 — notice of proposed sale of securities
Actionable Insight • Neutral
Monitor for subsequent Form 4 filings to confirm execution; the 10b5-1 plan reduces signaling value. No immediate trading catalyst from this filing alone.
Latest settled — T+20d
QURE ▼ -11.29% at T+20d
NEUTRAL call ✗ call lost -11.29% · α vs SPY -9.11% · entry $45.17 → $40.07
Latest observation: T+57 -72.42% FF3 residual α
T+1d
-7.44%
call -7.44% · α -7.31%
$41.81
settled 3mo ago
T+5d
-8.32%
call -8.32% · α -8.59%
$41.41
settled 3mo ago
T+20d
-11.29%
call -11.29% · α -9.11%
$40.07
settled 2mo ago
T+60d
—
call — · α —
—
due 8d ago
Price Chart
Loading chart...
Executive Summary
Director Jack Kaye filed a Form 144 to sell 21,167 ordinary shares (~$983K) as part of a pre-existing 10b5-1 plan adopted in June 2025. The sale is routine and represents a small fraction of the company's $3.0B market cap, with no material signaling value.
Key Facts
- Director Jack Kaye filed Form 144 to sell 21,167 ordinary shares.
- Estimated market value of proposed sale: $983,032.57.
- Sale is pursuant to a 10b5-1 trading plan adopted June 16, 2025.
- Prior sales by same insider in June 2026: 2,645 shares (06/03), 1,993 shares (06/11), 5,295 shares (06/17).
- Proposed sale represents ~0.033% of market cap.
Financial Impact
Proposed sale of ~$983K, small relative to $3.0B market cap.
dilution
Risk Factors
- Insider selling could accelerate if plan is modified, but current plan is pre-scheduled.
Market Snapshot
Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
76% bullish (21 analysts)
Investment Themes
Biotech & Drug Discovery
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 144 Filing (Primary) | 0001973379-26-000260 |
| Document: 0001973379-26-000260-index.html | 0001973379-26-000260 |
| Document: 0001973379-26-000260.txt | 0001973379-26-000260 |
32 reports for QURE
67% Hit rate best @ T+20▲ +27.15%
Filters
Rows
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 2, 2026 4w ago | 8-K | $46.23 $44.47 | ▼ −3.81% | ▼ −2.85% | $23.46 (−49.25%) |
Jul 29, 2026 9w ago | 8-K | $40.07 $44.24 | ▲ +10.41% | ▲ +4.88% | $23.46 (−41.45%) |
Jul 7, 2026 12w ago | Insider Cluster | $41.41 $41.52 | ▼ −0.27% | ▲ +0.29% | $23.46 (+43.35%) |
Jul 2, 2026 13w ago | Insider Cluster | $41.81 $44.48 | ▼ −6.39% | ▼ −5.46% | $23.46 (+43.89%) |
Jul 2, 2026 13w ago | Insider Cluster | $41.81 $44.48 | ▲ +6.39% | ▲ +5.46% | $23.46 (−43.89%) |
Jul 2, 2026 13w ago | 144 | $41.81 $44.48 | ▲ +6.39% | ▲ +5.46% | $23.46 (−43.89%) |
Jun 30, 2026 13w ago | 144 | $45.17 $41.41 | ▼ −8.32% | ▼ −8.59% | $23.46 (−48.06%) |
Jun 25, 2026 14w ago | 144 | $47.51 $41.81 | ▲ +12.00% | ▲ +14.16% | $23.46 (+50.62%) |
Jun 24, 2026 14w ago | 424B5 | $49.10 $45.17 | ▼ −8.00% | ▼ −9.56% | $23.46 (−52.22%) |
Jun 24, 2026 14w ago | 144 | $49.10 $45.17 | ▼ −8.00% | ▼ −9.56% | $23.46 (−52.22%) |
Showing 10 of 32
US Market Status
Market Closed — Opens Mon (64h 21m)
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access